Funding Ottawa Cancer Research
In just three years, Ride the Rideau has raised more than $6.4 million for cancer research at the Ottawa Hospital Research Institute (OHRI), making it the most successful single-day cancer fundraiser in Eastern Ontario.
Riders have already helped shaped the future of cancer care. In 2011, funding from Ride the Rideau helped build the new Centre for Innovative Cancer Research (CICR): a unique, world-class laboratory that is enabling our researchers to rapidly move their discoveries into the clinic to benefit patients.
Our cancer research team is focusing on the use of viruses, cells, and genes to develop therapies that are considered to have the most potential for eradicating cancer. The opening of the CICR is helping us achieve our goal of cutting in half the time between lab discoveries and patient trials. Laboratory scientists and clinicians work together every day to develop the next generation of therapies, which will be customized to each patient and won’t have the traditional side effects of chemotherapy and radiation.
There are currently more than 200 cancer-related clinical trials underway at The Ottawa Hospital Cancer Centre and another 140 research projects at OHRI. Here are just some of our leading researchers and clinical investigators who are changing the future of cancer care and are also part of our Ride the Rideau family.
- Dr. John Bell, leader in developing oncolytic virus therapies, which use viruses to attack cancer cells
- Dr. Mark Clemons, breaking new ground in personalized treatment for breast cancer patients
- Dr. Ian Lorimer, developing new ways to halt cancer growth; improving personalized cancer therapy
- Dr. Roanne Segal, exploring post-treatment lifestyles that minimize or enhance the risk of reoccurrence
For more information on the cancer therapeutics program at the Ottawa Hospital Research Institute, click here.